On Tuesday, Ionis Pharmaceuticals Inc (NASDAQ: IONS) opened lower -3.25% from the last session, before settling in for the closing price of $81.51. Price fluctuations for IONS have ranged from $23.95 to $83.61 over the past 52 weeks.
Company’s average yearly earnings per share was noted 24.02% at the time writing. With a float of $158.82 million, this company’s outstanding shares have now reached $161.14 million.
Ionis Pharmaceuticals Inc (IONS) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Ionis Pharmaceuticals Inc is 1.95%, while institutional ownership is 103.61%. The most recent insider transaction that took place on Dec 01 ’25, was worth 2,262,848. In this transaction Director of this company sold 28,000 shares at a rate of $80.82, taking the stock ownership to the 36,035 shares. Before that another transaction happened on Dec 01 ’25, when Company’s Director proposed sale 14,479 for $81.99, making the entire transaction worth $1,187,133.
Ionis Pharmaceuticals Inc (IONS) Latest Financial update
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.43 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.84) by 0.41. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.56 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 24.02% per share during the next fiscal year.
Ionis Pharmaceuticals Inc (NASDAQ: IONS) Trading Performance Indicators
Check out the current performance indicators for Ionis Pharmaceuticals Inc (IONS). In the past quarter, the stock posted a quick ratio of 2.78. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 13.20.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.71, a number that is poised to hit -1.32 in the next quarter and is forecasted to reach -3.18 in one year’s time.
Technical Analysis of Ionis Pharmaceuticals Inc (IONS)
Ionis Pharmaceuticals Inc (NASDAQ: IONS) saw its 5-day average volume 2.0 million, a negative change from its year-to-date volume of 2.07 million. As of the previous 9 days, the stock’s Stochastic %D was 48.19%.
During the past 100 days, Ionis Pharmaceuticals Inc’s (IONS) raw stochastic average was set at 89.10%, which indicates a significant increase from 59.68% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.42 in the past 14 days, which was higher than the 2.05 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $73.86, while its 200-day Moving Average is $47.99. Nevertheless, the first resistance level for the watch stands at $80.62 in the near term. At $82.37, the stock is likely to face the second major resistance level. The third major resistance level sits at $83.52. If the price goes on to break the first support level at $77.71, it is likely to go to the next support level at $76.56. The third support level lies at $74.81 if the price breaches the second support level.
Ionis Pharmaceuticals Inc (NASDAQ: IONS) Key Stats
There are currently 161,974K shares outstanding in the company with a market cap of 12.77 billion. Presently, the company’s annual sales total 705,140 K according to its annual income of -453,900 K. Last quarter, the company’s sales amounted to 156,720 K and its income totaled -128,610 K.
